Research reviewed by Gram found that daily fish oil, alone or with vitamin D, was linked to lower LDH, a marker of red blood cell breakdown, in adults with sickle cell anemia over six months. In a 2026 randomized trial of 183 adults, vitamin D alone showed no clear benefit on this marker.
Sickle cell anemia causes red blood cells to break down too early, which can lead to pain, fatigue, and other health problems. According to research reviewed by Gram, a six-month clinical trial with 183 adults found that daily fish oil, with or without vitamin D, was linked to lower levels of a marker of red blood cell breakdown called LDH. Fish oil also changed the types of fats found inside participants’ red blood cells. Vitamin D alone did not show a clear benefit on red blood cell breakdown. Because some participants did not follow the study plan and many dropped out, the researchers urged caution. The results suggest fish oil may be a promising area for future research, but it is not yet a proven treatment.
Key Statistics
A 2026 randomized, placebo-controlled trial of 183 adults with sickle cell anemia found that fish oil, alone or with vitamin D, was associated with significant changes in LDH, a marker of red blood cell breakdown, over six months.
In a 2026 six-month trial, participants who completed the study and took fish oil alone saw LDH levels drop by 39.81%, while those taking fish oil plus vitamin D saw a 26.86% drop.
A 2026 clinical trial of 183 adults with sickle cell anemia found that vitamin D alone did not produce a significant change in hemolysis markers compared with placebo.
The Quick Take
- What they studied: Can daily fish oil and vitamin D supplements reduce the breakdown of red blood cells in adults with sickle cell anemia, and do they change the fats inside those cells?
- Who participated: 183 adults with sickle cell anemia were enrolled. 170 were included in the main analysis. Some participants also took hydroxyurea or received blood transfusions, and the researchers accounted for these treatments in their calculations.
- Key finding: Participants taking fish oil, alone or with vitamin D, showed meaningful decreases in LDH, a marker of red blood cell breakdown, over six months. In one group of participants who finished the study, LDH dropped by about 27% with fish oil plus vitamin D and about 40% with fish oil alone. Vitamin D alone did not show a clear effect on this marker.
- What it means for you: If you or someone you care about has sickle cell anemia, fish oil may be worth discussing with a hematologist. This study does not prove fish oil helps, and supplements should never replace your prescribed treatment or be started without medical guidance.
The Research Details
Researchers ran a six-month clinical trial in which adults with sickle cell anemia were randomly assigned to one of four groups. One group took fish oil and vitamin D, one took only fish oil, one took only vitamin D, and one took placebo pills that looked the same. Random assignment means chance decided who got which treatment, which helps make the groups more comparable.
The fish oil provided 900 mg of EPA and 600 mg of DHA daily, two omega-3 fats found in fish. The vitamin D dose was 4,285 IU daily. Participants had blood drawn at the start, at three months, and at six months so the team could track changes over time. The study was single-blind, meaning participants did not know which pills they were taking, but the research team did.
Because some people missed visits or dropped out, the researchers used a statistical method that makes use of all the data each person provided. They also adjusted their results for other treatments, such as hydroxyurea and blood transfusions, that could affect the outcomes.
A randomized, placebo-controlled design is one of the strongest ways to test whether a supplement causes a change. Using placebo pills helps separate the real effect of a supplement from expectations or chance. Measuring blood markers at several points lets researchers see the direction and timing of changes, not just a single snapshot.
The trial had several strengths, including random assignment, a placebo comparison, and repeated blood tests. However, the researchers reported that 13 participants were assigned to groups outside the planned random sequence, and a substantial number of people dropped out before the study ended. These issues can affect results, which is why the authors described their findings as needing cautious interpretation. The trial was also single-blind rather than double-blind, which leaves some room for bias. The study was registered in the Brazilian clinical trials registry (ReBEC), which helps show the plan was set in advance.
What the Results Show
The main finding involved LDH, an enzyme that rises when red blood cells break down. The statistical test showed that the change over time differed between groups (p less than 0.001), and LDH levels decreased from the start to six months in the groups taking fish oil, both with and without vitamin D. The researchers also saw a smaller but statistically significant pattern for heme, a component of hemoglobin that is released when red blood cells break apart (p = 0.016).
The fats inside red blood cells also changed. Several saturated fats, including lauric, myristic, palmitic, and stearic acids, showed significant differences between groups. Levels of some omega-6 and omega-3 fats, including DHA, also changed in the fish oil groups. In the groups without fish oil, several of these fats moved in the opposite direction, which shows that the supplements affected the composition of the cells.
Some results did not reach statistical significance. Levels of EPA rose in the fish oil groups, but the overall group comparison was not statistically significant (p = 0.586). The ratio between omega-6 and omega-3 fats also did not show a clear group difference (p = 0.602). Bilirubin, another marker related to red blood cell breakdown, did not show a significant group difference over time, although it decreased by roughly 20% in both fish oil groups among participants who finished the study.
Among participants who completed the six-month study, the fish oil groups showed the largest drops in LDH, with about a 27% decrease in the fish oil plus vitamin D group and about a 40% decrease in the fish oil alone group. These are promising numbers, but they come from a smaller subset of people and were not the main planned comparison, so they should be viewed as supporting evidence rather than proof. Changes in the fats inside red blood cells suggest the supplements were absorbed and reached the cells, which helps explain how fish oil could influence the body. Vitamin D alone did not appear to change hemolysis markers in a meaningful way.
Earlier research has suggested that omega-3 fatty acids may have anti-inflammatory effects and may support red blood cell health, and that low vitamin D is common in people with sickle cell anemia. This trial adds more rigorous evidence by testing these supplements in a placebo-controlled design over six months. Its findings fit with the idea that fish oil may help, while the lack of a clear benefit from vitamin D alone adds nuance to the idea that vitamin D fixes the problem by itself. Larger and longer studies are still needed to confirm these patterns.
The biggest limitations were the number of participants who dropped out and the 13 people who did not follow their assigned random sequence. Missing data can distort results, even when statistical methods are used to fill gaps. The single-blind design also means that expectations could have influenced how participants reported symptoms, although lab measurements like LDH are less affected by expectations. Many of the most striking percentage drops came from the group of participants who completed the study, so they may not represent everyone. The trial lasted only six months, so it cannot show whether benefits last longer or whether there are long-term risks. Finally, the results are from adults, and children with sickle cell anemia were not studied here.
The Bottom Line
Research shows that daily fish oil, alone or with vitamin D, was associated with lower LDH levels over six months in adults with sickle cell anemia, which is a promising signal. Confidence is moderate because the trial had dropouts and deviations from the plan. Vitamin D alone showed no clear benefit on red blood cell breakdown in this study. People with sickle cell anemia should talk with their hematologist before starting fish oil, since supplements can interact with medications and affect bleeding risk in some people.
Adults with sickle cell anemia and the clinicians who care for them may find these results worth discussing. Caregivers and researchers planning future studies should also pay attention. People who do not have sickle cell anemia should not use these findings to justify taking fish oil for red blood cell health, since the study focused only on this condition. Children, pregnant people, and anyone taking blood-thinning medication should speak with a doctor first.
In this trial, changes in LDH appeared within three to six months. Changes in the fats inside red blood cells also developed over that period, since red blood cells are replaced gradually. Anyone considering supplements should expect that any possible effect would take months rather than days or weeks, and should review progress with their care team rather than assuming a benefit.
Frequently Asked Questions
Can fish oil help with sickle cell anemia?
A 2026 randomized trial of 183 adults found that fish oil, alone or with vitamin D, was associated with lower LDH, a marker of red blood cell breakdown, over six months. The results are promising but not yet definitive, so talk with a hematologist before starting.
Does vitamin D help reduce red blood cell breakdown in sickle cell anemia?
In a six-month trial of 183 adults, vitamin D alone did not produce a significant benefit on markers of red blood cell breakdown compared with placebo. Vitamin D appeared to have effects only when combined with fish oil in the study’s analysis.
How much fish oil did people take in the sickle cell anemia study?
Participants took a daily dose providing 900 mg of EPA and 600 mg of DHA, two omega-3 fats found in fish. The fish oil was studied over six months, with blood tests at the start, three months, and six months.
Is fish oil safe for people with sickle cell anemia?
The trial was designed to measure blood markers, and it did not report any single safety conclusion in the summary provided. Fish oil can interact with blood thinners and other medications, so people with sickle cell anemia should check with their doctor before starting.
Want to Apply This Research?
- Log your daily supplement doses, including fish oil and vitamin D amounts, and record any lab results your doctor shares, such as LDH, hemoglobin, or bilirubin levels. Note the date of each blood test so you can see trends over three to six months.
- Set a daily reminder to take your prescribed supplements at the same time each day, and use the app to check off each dose. Consistent dosing matters because the trial measured changes over months, and missed doses can make it harder to tell what is working.
- Review your logged supplement habits and lab results with your hematologist every three months. Track symptoms such as pain episodes, fatigue, and jaundice alongside lab values, and share the summary at each appointment. Update your plan only with medical guidance, and log any side effects or new medications so your care team has a complete picture.
This article summarizes a single clinical trial for general education and is not medical advice. Sickle cell anemia is a serious condition, and people with it should not start, stop, or change any supplement or prescribed treatment, including hydroxyurea, without first talking with their hematologist or healthcare team. Supplements can interact with medications and may not be appropriate for everyone. Always seek urgent medical care for severe pain, fever, trouble breathing, or other emergency symptoms.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.